Metformin + Pioglitazone + Voglibose is primarily used to improve blood sugar control in adults with type 2 diabetes. It belongs to the group of antidiabetic medicines.
This combination therapy is also considered when dual therapy with metformin and another oral antidiabetic agent is not sufficient to achieve the desired blood sugar levels.
Abdominal pain
Diarrhoea
Nausea
Headache
Weight gain
Metformin + Pioglitazone + Voglibose is a combination medicine for managing type 2 diabetes mellitus.
Metformin decreases glucose production in the liver, reduces glucose absorption in the intestines, and improves insulin sensitivity. This means it helps your body use insulin more efficiently to lower the amount of sugar in your blood.
Pioglitazone enhances insulin sensitivity in the muscles and fat tissues and reduces glucose production in the liver. This helps your body use its natural insulin better and also slows down the release of sugars stored in your liver.
Voglibose delays the digestion and absorption of carbohydrates in the intestines, leading to a slower and lower rise in blood sugar after meals. This helps to reduce sudden spikes in your blood sugar levels.
Together, these three components work in harmony to control blood sugar levels throughout the day and prevent complications of diabetes.
Bachelor of Dental Surgery
Doctor of Medicine
Metformin + Pioglitazone + Voglibose is available for oral use in the form of tablets.
This medicine is meant for adults of age above 18 years. It is not recommended for use in children and adolescents.
This combination therapy is contraindicated in patients with type 1 diabetes.
Individuals with diabetic ketoacidosis must avoid it.
Patients with severe renal impairment should not take this medication.
Those with known hypersensitivity to metformin, pioglitazone, or voglibose should also not use this combination.
Metformin + Pioglitazone + Voglibose may interact with insulin, sulfonylureas (such as gliclazide and glipizide), cationic medicines (like cimetidine, amiloride, and digoxin), CYP2C8 inhibitors (such as gemfibrozil) and CYP2C8 inducers (like rifampicin).
An overdose of Metformin + Pioglitazone + Voglibose may cause hypoglycaemia or lactic acidosis. If you suspect an overdose, seek immediate medical attention.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed one and continue with your regular dosing schedule.
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
Gastrointestinal side effects can be managed by taking the medication with meals.
For managing headaches, taking rest and staying hydrated can be helpful.
Metformin + Pioglitazone + Voglibose does not usually affect your ability to drive or operate machinery. However, if you experience dizziness or blurred vision after taking this medicine, avoid driving or operating machinery.
Metformin + Pioglitazone + Voglibose should be used during pregnancy and breastfeeding only if the potential benefits justify the potential risk to the foetus or child. It is advisable to consult your doctor before using this medicine during these periods.
Patients with congestive heart failure and hepatic impairment should use Metformin + Pioglitazone + Voglibose with caution and under regular monitoring.
Smoking cessation and limiting alcohol intake can help manage the symptoms of type 2 diabetes.
Regular check-ups with your doctor are beneficial in tracking your progress and adjusting your medication if needed.
Frequently asked questions
No, Metformin + Pioglitazone + Voglibose is not a steroid. This combination of medicines belongs to the group of antidiabetic medications.
Metformin + Pioglitazone + Voglibose is not associated with affecting sleep. However, any unusual changes in sleep patterns should be reported to your doctor.
Metformin + Pioglitazone + Voglibose is not directly associated with affecting fertility. If you are concerned about fertility issues, please consult your doctor.
Yes, Metformin + Pioglitazone + Voglibose is typically taken daily as per your doctor's prescription.
The effects of Metformin + Pioglitazone + Voglibose can usually be observed within a few weeks of starting treatment, with the maximum effect seen in 2-3 months.
Metformin + Pioglitazone + Voglibose is a prescription medication and is not available over the counter.
Each component of this combination has a different half-life: metformin's half-life is about 6 hours, pioglitazone's half-life is around 5 to 6 hours, and voglibose's half-life is approximately 1 hour.
Metformin + Pioglitazone + Voglibose in other salts
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.4.16
Our Payment Partners